Which treatment regimens for diffuse large B-cell lymphoma (DLBCL) are indicated in elderly patients with comorbidities?

Updated: Feb 23, 2021
  • Author: Mohammad Muhsin Chisti, MD, FACP; Chief Editor: Emmanuel C Besa, MD  more...
  • Print

Regimens for patients >80 years of age with comorbidities are as follows:

  • R-mini-CHOP
  • RGCVP (rituximab, gemcitabine, cyclophosphamide, vincristine, prednisolone)

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!